← Browse by Condition
Medical Condition

advanced tumors

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06788938 Phase 2
Recruiting

Tarlatamab in Advanced Delta-like 3 (DLL3)-Expressing Tumors Including Neuroendocrine Neoplasms

Enrollment
29 pts
Location
United States
Sponsor
Jonsson Comprehensive Cancer C...
View Trial →